New drug combo tested for Tough-to-Treat pancreatic cancer

This early-stage study is testing whether adding an experimental drug called zolbetuximab to standard chemotherapy is safe for people with advanced pancreatic cancer that has spread. Zolbetuximab works by attaching to a specific protein on cancer cells to help the immune system attack the tumor. The study will enroll 12 adults with a specific tumor marker who haven't had chemotherapy before, primarily checking for side effects and how well the combination is tolerated.